Cargando…

Corrigendum: Metabolic Reprogramming During Multidrug Resistance in Leukemias

Detalles Bibliográficos
Autores principales:	Vidal, Raphael Silveira, Quarti, Julia, Rodrigues, Mariana Figueiredo, Rumjanek, Franklin D., Rumjanek, Vivian M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241210/ https://www.ncbi.nlm.nih.gov/pubmed/30460192 http://dx.doi.org/10.3389/fonc.2018.00441

Ejemplares similares

Metabolic Reprogramming During Multidrug Resistance in Leukemias
por: Vidal, Raphael Silveira, et al.
Publicado: (2018)

Selective Cytotoxicity of Piperine over Multidrug Resistance Leukemic Cells
por: Quarti, Julia, et al.
Publicado: (2021)

Corrigendum: Isothermal Microcalorimetry of Tumor Cells: Enhanced Thermogenesis by Metastatic Cells
por: Lemos, Douglas, et al.
Publicado: (2020)

Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR–CML cell lines?
por: Rumjanek, Vivian M., et al.
Publicado: (2013)

Detachment of Hexokinase II From Mitochondria Promotes Collateral Sensitivity in Multidrug Resistant Chronic Myeloid Leukemia Cells
por: Oliveira, Thaís, et al.
Publicado: (2022)

Osmolyte Induced Tumorigenesis and Metastasis: Interactions With Intrinsically Disordered Proteins
por: Rumjanek, Franklin D.
Publicado: (2018)

Isothermal Microcalorimetry of Tumor Cells: Enhanced Thermogenesis by Metastatic Cells
por: Lemos, Douglas, et al.
Publicado: (2019)

How does the metabolism of tumour cells differ from that of normal cells
por: Amoêdo, Nívea Dias, et al.
Publicado: (2013)

Methyl Jasmonate: Putative Mechanisms of Action on Cancer Cells Cycle, Metabolism, and Apoptosis
por: Cesari, Italo Mario, et al.
Publicado: (2014)

Metabolic Profile of Oral Squamous Carcinoma Cell Lines Relies on a Higher Demand of Lipid Metabolism in Metastatic Cells
por: Sant’Anna-Silva, Ana Carolina B., et al.
Publicado: (2018)

Ouabain Affects the Expression of Activation Markers, Cytokine Production, and Endocytosis of Human Monocytes
por: Teixeira, Mariana Pires, et al.
Publicado: (2014)

Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia
por: Maia, Raquel C., et al.
Publicado: (2018)

Ouabain inhibits monocyte activation in vitro: prevention of the proinflammatory mCD14(+)/CD16(+) subset appearance and cell-size progression
por: Valente, Raphael C, et al.
Publicado: (2012)

Mitochondrial Uncoupling and the Reprograming of Intermediary Metabolism in Leukemia Cells
por: Vélez, Juliana, et al.
Publicado: (2013)

Sensitivity of Dendritic Cells to Microenvironment Signals
por: Motta, Juliana Maria, et al.
Publicado: (2016)

Energy Metabolism in H460 Lung Cancer Cells: Effects of Histone Deacetylase Inhibitors
por: Amoêdo, Nívea Dias, et al.
Publicado: (2011)

Targeting chemoresistance and mitochondria-dependent metabolic reprogramming in acute myeloid leukemia
por: Feng, Lili, et al.
Publicado: (2023)

Mechanism Underlying the Reversal of Drug Resistance in P-Glycoprotein-Expressing Leukemia Cells by Pinoresinol and the Study of a Derivative
por: González, María L., et al.
Publicado: (2017)

Editorial: Metabolic reprogramming for acquiring therapeutic resistance in glioblastoma
por: Hsu, Tsung-I
Publicado: (2023)

Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming
por: Adeshakin, Funmilayo O., et al.
Publicado: (2021)

Relationship between metabolic reprogramming and drug resistance in breast cancer
por: Lv, Linlin, et al.
Publicado: (2022)

Energy and Redox Homeostasis in Tumor Cells
por: de Oliveira, Marcus Fernandes, et al.
Publicado: (2012)

Tumor-Released Products Promote Bone Marrow-Derived Macrophage Survival and Proliferation
por: Motta, Juliana Maria, et al.
Publicado: (2021)

Metabolic reprogramming of three major nutrients in platinum-resistant ovarian cancer
por: Yan, Jinbowen, et al.
Publicado: (2023)

Editorial: Therapy resistance in tumor microenvironment: metabolic reprogramming and purinergic signaling
por: Zanoni, Michele, et al.
Publicado: (2023)

Metabolic Reprogramming in Thyroid Carcinoma
por: Coelho, Raquel Guimaraes, et al.
Publicado: (2018)

STAT3-Mediated Metabolic Reprograming in Cellular Transformation and Implications for Drug Resistance
por: Poli, Valeria, et al.
Publicado: (2015)

Metabolic Reprogramming in Adipose Tissue During Cancer Cachexia
por: Weber, Bahar Zehra Camurdanoglu, et al.
Publicado: (2022)

Macrophages and Metabolic Reprograming in the Tumor Microenvironment
por: Liu, Jin, et al.
Publicado: (2022)

Editorial: Metabolic reprogramming in breast cancer
por: Scatena, Cristian, et al.
Publicado: (2022)

CD147 Mediates 5-Fluorouracil Resistance in Colorectal Cancer by Reprogramming Glycolipid Metabolism
por: Dong, Shuohui, et al.
Publicado: (2022)

Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma
por: Prasopporn, Sunisa, et al.
Publicado: (2023)

Editorial: Cell Stress, Metabolic Reprogramming, and Cancer
por: Giannattasio, Sergio, et al.
Publicado: (2018)

Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Sun, Xiangyu, et al.
Publicado: (2020)

Editorial: Hallmark of cancer: Reprogramming of cellular metabolism
por: Kaur, Baljinder, et al.
Publicado: (2023)

Lipid metabolism reprogramming in head and neck cancer
por: Liang, Jinfeng, et al.
Publicado: (2023)

Corrigendum: Murine models of acute myeloid leukemia
por: Kurtz, Kristen J., et al.
Publicado: (2023)

Molecular Imaging of Metabolic Reprograming in Mutant IDH Cells
por: Viswanath, Pavithra, et al.
Publicado: (2016)

Influence of the Tumor Microenvironment on Cancer Cells Metabolic Reprogramming
por: Gouirand, Victoire, et al.
Publicado: (2018)

Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints
por: Xu, Yaolin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m5qfle6uiqpf9ddnl57t3fb06u